JPWO2022023450A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022023450A5
JPWO2022023450A5 JP2023505376A JP2023505376A JPWO2022023450A5 JP WO2022023450 A5 JPWO2022023450 A5 JP WO2022023450A5 JP 2023505376 A JP2023505376 A JP 2023505376A JP 2023505376 A JP2023505376 A JP 2023505376A JP WO2022023450 A5 JPWO2022023450 A5 JP WO2022023450A5
Authority
JP
Japan
Prior art keywords
cancer
compound
carboxylic acid
phanephos
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023505376A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535595A5 (https=
JP2023535595A (ja
JP7832924B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/071219 external-priority patent/WO2022023450A1/en
Publication of JP2023535595A publication Critical patent/JP2023535595A/ja
Publication of JP2023535595A5 publication Critical patent/JP2023535595A5/ja
Publication of JPWO2022023450A5 publication Critical patent/JPWO2022023450A5/ja
Application granted granted Critical
Publication of JP7832924B2 publication Critical patent/JP7832924B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023505376A 2020-07-28 2021-07-28 縮合二環式raf阻害剤のキラル合成 Active JP7832924B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063057531P 2020-07-28 2020-07-28
US63/057,531 2020-07-28
PCT/EP2021/071219 WO2022023450A1 (en) 2020-07-28 2021-07-28 Chiral synthesis of fused bicyclic raf inhibitors

Publications (4)

Publication Number Publication Date
JP2023535595A JP2023535595A (ja) 2023-08-18
JP2023535595A5 JP2023535595A5 (https=) 2024-08-06
JPWO2022023450A5 true JPWO2022023450A5 (https=) 2024-08-06
JP7832924B2 JP7832924B2 (ja) 2026-03-18

Family

ID=77564067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023505376A Active JP7832924B2 (ja) 2020-07-28 2021-07-28 縮合二環式raf阻害剤のキラル合成

Country Status (10)

Country Link
US (2) US20220041595A1 (https=)
EP (1) EP4188923A1 (https=)
JP (1) JP7832924B2 (https=)
KR (1) KR20230058630A (https=)
CN (1) CN116348465B (https=)
AU (1) AU2021318923A1 (https=)
CA (1) CA3187393A1 (https=)
IL (1) IL300110A (https=)
MX (1) MX2023001274A (https=)
WO (1) WO2022023450A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023535790A (ja) 2020-07-28 2023-08-21 ジャズ ファーマシューティカルズ アイルランド リミテッド 縮合二環式raf阻害薬及びその使用方法
CN114921508B (zh) * 2022-07-22 2022-10-11 常熟药明康德新药开发有限公司 (r)-6-羟基色满-3-羧酸的生物催化制备方法
JP2025539426A (ja) 2022-11-29 2025-12-05 ジャズ ファーマシューティカルズ アイルランド リミテッド (s)-5-((3-(4-(4-フルオロフェニル)-1h-イミダゾール-2-イル)クロマン-6-イル)オキシ)-3,4-ジヒドロ-1,8-ナフチリジン-2(1h)-オンの結晶形態
EP4665725A2 (en) * 2023-02-17 2025-12-24 Jazz Pharmaceuticals Ireland Limited Methods of treating solid tumors with mitogen activated protein kinase (mapk) pathway alterations

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932657A (en) 1973-11-12 1976-01-13 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome encapsulation of chelating agents
GB1575343A (en) 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4452747A (en) 1982-03-22 1984-06-05 Klaus Gersonde Method of and arrangement for producing lipid vesicles
JPS6058915A (ja) 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
US4744989A (en) 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5736155A (en) 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4830858A (en) 1985-02-11 1989-05-16 E. R. Squibb & Sons, Inc. Spray-drying method for preparing liposomes and products produced thereby
US4921757A (en) 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
JPH0617309B2 (ja) 1985-11-29 1994-03-09 株式会社ビタミン研究所 アドリアマイシン包埋リポソ−ム製剤
DE3611229A1 (de) 1986-04-04 1987-10-08 Basf Ag Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinoidpraeparaten
MX9203808A (es) 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5766635A (en) 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
DE69529054T2 (de) 1994-02-28 2003-08-21 Nanopharm Ag System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
US5800833A (en) 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
EP0825852B1 (en) 1995-04-18 2004-07-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Liposome drug-loading method and composition
US8137699B2 (en) 2002-03-29 2012-03-20 Trustees Of Princeton University Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
US7850990B2 (en) 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
CA2462376C (en) 2001-10-03 2010-12-14 Celator Technologies Inc. Liposome loading with metal ions
CA2467064C (en) 2001-11-13 2011-02-08 Murray Webb Lipid carrier compositions with enhanced blood stability
LT2653465T (lt) * 2004-03-15 2016-09-12 Janssen Pharmaceutica Nv Opioidinio receptoriaus moduliatoriai
JP5001263B2 (ja) * 2005-05-20 2012-08-15 ドクター レディズ ラボラトリーズ (イーユー) リミテッド ジフェニルアラニン誘導体作製のための不斉水素化
GB201416186D0 (en) * 2014-09-12 2014-10-29 Redx Pharma Ltd Compounds
CN109503659B (zh) * 2019-01-03 2021-06-18 凯特立斯(深圳)科技有限公司 氧杂螺环双膦配体及其在α,β-不饱和羧酸不对称氢化中的应用

Similar Documents

Publication Publication Date Title
CN112142735B (zh) 一类稠和氰基吡啶类化合物、制备方法和用途
CN112300194B (zh) 一类稠环吡啶酮类化合物、制备方法和用途
CN113754683A (zh) 同位素取代的螺芳环化合物及其应用
AU2021400942A1 (en) PRMT5 inhibitors
AU2022217791A9 (en) Tricyclic-amido-bicyclic prmt5 inhibitors
CN112300160A (zh) 一种螺芳环化合物、其制备及应用
Mu et al. Access to phosphine-containing quinazolinones enabled by photo-induced radical phosphorylation/cyclization of unactivated alkenes
CN114195804A (zh) 一类哌啶稠环类化合物、制备方法和用途
JP2018532737A5 (https=)
JP2019537610A (ja) Fgfr4阻害剤、その製造方法と薬学的な応用
JP2021529182A (ja) Trk阻害剤としてのヘテロ環化合物
KR102421137B1 (ko) 아미노치환 질소함유 축합고리 화합물 및 그의 제조방법과 용도
JP7832924B2 (ja) 縮合二環式raf阻害剤のキラル合成
CN116157128A (zh) 吡唑并哒嗪酮化合物、其药物组合物及其用途
TWI913048B (zh) 嘧啶並噻喃酮kras突變蛋白抑制劑的製備及其應用
CN110950876B (zh) 一类呋喃并内酰胺类化合物、制备方法和用途
JPWO2022023450A5 (https=)
CN112778294A (zh) 5-氨基异噁唑衍生物及其在制备多激酶抑制剂中的应用
JP7152794B2 (ja) Fgfr阻害剤、その製造方法および応用
CN113906021A (zh) 手性吲哚化合物及其用途
CN106317055A (zh) 一类具有激酶抑制活性的化合物、制备方法和用途
CN116903609A (zh) 一种化合物、包含其的药物组合物及其应用
CN111039941B (zh) 一种含氮杂环化合物、其制备方法及应用
JP2026509288A (ja) 芳香族アミド誘導体、その製造方法、およびその使用
JP2025541854A (ja) カンプトテシン誘導体、医薬組成物及びその製造方法と使用